bendroflumethiazide has been researched along with Drug-Induced Stevens Johnson Syndrome in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, IW | 1 |
| Montgomery, PR | 1 |
| Peachey, RD | 1 |
1 other study available for bendroflumethiazide and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Toxic epidermal necrolysis and malignant lymphoma.
Topics: Adult; Aged; Bendroflumethiazide; Chloramphenicol; Cyclizine; Female; Hodgkin Disease; Humans; Lymph | 1967 |